Johanna Mercier's Net Worth
$17.9 Million
Who is Johanna Mercier?
Johanna Mercier has an estimated net worth of $17.9 Million. This is based on reported shares across multiple companies, which include GILEAD SCIENCES, INC., NEUROCRINE BIOSCIENCES INC, and Arcus Biosciences, Inc..
SEC CIK
Johanna Mercier's CIK is 0001782135
Past Insider Trading and Trends
2023 was Johanna Mercier's most active year for acquiring shares with 12 total transactions. Johanna Mercier's most active month to acquire stocks was the month of February. 2023 was Johanna Mercier's most active year for disposing of shares, totalling 12 transactions. Johanna Mercier's most active month to dispose stocks was the month of February. 2022 saw Johanna Mercier paying a total of $0.00 for 245,326 shares, this is the most they've acquired in one year. In 2024 Johanna Mercier cashed out on 67,722 shares for a total of $4,066,780.17, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GILEAD SCIENCES, INC. (GILD) Snapshot price: $78.52
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.40% | -5.00K |
$91.28 | -$456,400.00 | 73.13K |
Scheduled
|
Nov 6
| ||
Form 4
| -27.31% | -29.36K |
$83.78 | -$2,459,576.75 | 78.13K |
Scheduled
|
Sep 12
| ||
Form 4
| +1.91% | 2.02K |
$81.44 | -$141,216.96 | 107.48K |
Sep 10
| |||
Form 4
| -8.27% | -9.51K |
$78.03 | -$742,299.39 | 105.47K |
Scheduled
|
Aug 28
| ||
Form 4
| -4.56% | -5.49K |
$73.98 | -$406,150.20 | 114.98K |
Scheduled
|
Aug 13
| ||
Form 4
| +1.72% | 2.04K |
$65.25 | -$111,838.50 | 120.47K |
Jun 10
| |||
Form 4
| +4.67% | 5.29K |
$75.12 | -$342,472.08 | 118.43K |
Mar 10
| |||
Form 4
| +83.68% | 51.55K |
$78.26 | -$1,761,554.34 | 113.15K |
Jan 31
| |||
Form 4
| -9.06% | -8.24K |
$85.23 | -$702,465.66 | 82.73K |
Scheduled
|
Jan 9
| ||
Form 4
| +1.66% | 1.48K |
$79.02 | -$98,537.94 | 90.97K |
Dec 10
| |||
Form 4
| +1.67% | 1.47K |
$76.00 | -$95,456.00 | 89.49K |
Sep 10
| |||
Form 4
| +9.84% | 4.33K |
$77.66 | -$246,492.84 | 48.33K |
Jul 24
| |||
Form 4
| +3.43% | 1.46K |
$78.12 | -$99,368.64 | 43.99K |
Jun 10
| |||
Form 4
| +7.67% | 5.86K |
$79.50 | -$406,722.00 | 82.22K |
Mar 10
| |||
Form 4
| +214.31% | 52.07K |
$84.02 | -$1,287,606.50 | 76.36K |
Jan 24
| |||
Form 4
| +1.32% | 527 |
$87.97 | -$40,730.11 | 40.43K |
Dec 10
| |||
Form 4
| +1.35% | 532 |
$65.28 | -$29,898.24 | 39.9K |
Sep 10
| |||
Form 4
| +12.26% | 4.3K |
$60.80 | -$194,924.80 | 39.37K |
Jul 24
| |||
Form 4
| +1.53% | 528 |
$60.74 | -$28,061.88 | 35.07K |
Jun 10
| |||
Form 4
| +12.24% | 3.77K |
$57.92 | -$186,560.32 | 34.54K |
Mar 10
| |||
Form 4
| +153.36% | 18.63K |
—
|
—
| 30.78K |
Jan 26
| |||
Form 4
| +50.57% | 4.08K |
$69.02 | -$236,393.50 | 12.15K |
Jul 24
| |||
Form 4
| -70.73% | -19.50K |
$66.09 | -$1,288,547.18 | 8.07K |
May 4
| |||
Form 4
| +6.12% | 1.59K |
$63.91 | -$91,710.85 | 27.56K |
Mar 10
| |||
Form 4
| +45.06% | 8.07K |
—
|
—
| 25.97K |
Jan 26
| |||
Form 4
| +357.02% | 13.99K |
$58.83 | -$722,550.06 | 17.91K |
Nov 3
| |||
Form 4
|
∞
| 3.92K |
$73.64 | -$264,146.68 | 3.92K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEUROCRINE BIOSCIENCES INC (NBIX) Snapshot price: $120.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
∞
| 2.1K |
—
|
—
| 2.1K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||